Patent · US Active

Melanoma antigen peptide and uses thereof

US8975371B2 · kind B2 · utility

0Cited by

0References

5Claims

0Family size

Assignees

INSERM (INSTITUT NATIONAL DE LA SANTÉ ET DE LA RECHERCHE MÉDICALE) · FR
UNIVERSITE DE NANTES · FR
CHU NANTES · FR

Inventors

Nathalie Labarriere · Nantes, FR
Agnes Moreau-Aubry · Nantes, FR
Yann Godet · Nantes, FR

Key dates

Filing date	Nov 21, 2013
Grant date	Mar 10, 2015
Priority date	—
Expiry date	Nov 21, 2033

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K2239/57
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to novel melanoma antigen peptides and specific T lymphocytes directed to said peptides and the use thereof for treating melanoma.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.